New Kids' flu drug shows promise in major trial
NCT ID NCT07095257
First seen Nov 19, 2025 · Last updated May 13, 2026 · Updated 22 times
Summary
This study tested a new flu medicine called ZX-7101A in children aged 2 to 11. The goal was to see if it safely reduces flu symptoms like fever and cough compared to a standard treatment. 169 children took part, and researchers tracked side effects and how quickly symptoms improved.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY VIRAL INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
-
West China Second University Hospital, Sichuan University
Chengdu, Sichuan, China
Conditions
Explore the condition pages connected to this study.